Could XVIVO’s HOPE data change how long donor hearts can survive outside the body?
See how XVIVO’s PRESERVE Trial data could reshape donor heart preservation, FDA review, and transplant access.
Why VitaSmart’s FDA nod could shift transplant strategies for extended-criteria grafts
Find out how Bridge to Life’s FDA-cleared VitaSmart system could reshape liver transplant workflows in 2026.